Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

3- (3,4-Dihydroxyphenyl) -L-alanine

<strong>3-(3,4-Dihydroxyphenyl)-L-alanine</strong>_x000D_ <strong>Catalog number:</strong> B2018289_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 g_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> RT_x000D_ <strong>Keywords:</strong> L-DOPA, Levodopa_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease Mov Disord. 2010 Nov 15;25(15):2649-53._x000D_ 2: Haddad F, Sawalha M, Khawaja Y, Najjar A, Karaman R. Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease Molecules. 2017 Dec 25;23(1):40._x000D_ 3: Fahn S. The history of dopamine and levodopa in the treatment of Parkinson's disease Mov Disord. 2008;23 Suppl 3:S497-508._x000D_ 4: Ihara M, Tsuchiya Y, Sawasaki Y, Hisaka A, Takehana H, Tomimoto K, Yano M. A new potential prodrug to improve the duration of L-dopa: L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine J Pharm Sci. 1989 Jul;78(7):525-9._x000D_ 5: Levodopa for parkinsonism Br Med J. 1971 Jan 30;1(5743):244-5._x000D_ 6: Giritharan AB, Davis TL. Will Subcutaneous Levodopa Stick? Old Dog, New Trick Neurology. 2022 Sep 5;99(10):407-408._x000D_ 7: Bergström M, Lu L, Marquez M, Moulder R, Jacobsson G, Ogren M, Eriksson B, Watanabe Y, Långström B. Catechol-O-methyltransferase inhibition increases the uptake of 11C-3-(3,4-dihydroxyphenyl)-L-alanine in the rat pancreas Scand J Gastroenterol. 1996 Dec;31(12):1216-22._x000D_ 8: Abbruzzese G. Optimising levodopa therapy Neurol Sci. 2008 Dec;29 Suppl 5:S377-9._x000D_ 9: Mena MA, Casarejos MJ, Solano RM, de Yébenes JG. Half a century of L-DOPA Curr Top Med Chem. 2009;9(10):880-93._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/33978030">10: Giuri D, Ravarino P, Tomasini C. L-Dopa in small peptides: an amazing functionality to form supramolecular materials Org Biomol Chem. 2021 Jun 2;19(21):4622-4636. </a>_x000D_ _x000D_ <strong>Products Related to 3-(3,4-Dihydroxyphenyl)-L-alanine can be found at</strong> <a href="https://moleculardepot.com/product-category/Dyes/"> Dyes</a>

Product Specifications

Short Description

Catalog Number: B2018289 (1 g)

Weight

0.8

Length

2

Width

0.9

Height

0.9

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD10 (CB-CALLA), CF647 conjugate, 0.1mg/mL
BNC470146-500 1x 500 µL

CD10 (CB-CALLA), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
HSP27 (G3.1), CF488A conjugate, 0.1mg/mL
BNC880861-500 1x 500 µL

HSP27 (G3.1), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
TRP1 (Tyrosinase Related Protein 1) (TYRP1/807), CF640R conjugate, 0.1mg/mL
BNC400807-100 1x 100 µL

TRP1 (Tyrosinase Related Protein 1) (TYRP1/807), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Catenin, beta (CTNNB1) (CTNNB1/2098), CF488A conjugate, 0.1mg/mL
BNC882098-500 1x 500 µL

Catenin, beta (CTNNB1) (CTNNB1/2098), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (NX2/1422R), CF647 conjugate, 0.1mg/mL
BNC471422-500 1x 500 µL

NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (NX2/1422R), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD117 (KIT/982), CF647 conjugate, 0.1mg/mL
BNC470982-100 1x 100 µL

CD117 (KIT/982), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details